2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow telaprevir: new trials by email Literature Review of telaprevir trials Research Report on telaprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients Peginterferon alfa-2a, Ribavirin, telaprevir - Hepatitis C | Phase 4 | Terminated | University of Chicago | 3 | 2012-04-01 | 2016-06-15 |
| Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a - Hepatitis C | Phase 4 | Terminated | Vertex Pharmaceuticals Incorporated | 121 | 2012-01-01 | 2015-08-03 |
Hepatitis C (2)
University of Chicago (1) · Vertex Pharmaceuticals Incorporated (1)
United States (2)
Helen Te, MD (1)